Overview: News that the AstraZeneca (AZN) Phase 3 test had to be stopped to study the adverse reaction of one subject added to the uncertainty of investors amid one of the more significant reversals of risk appetites since March. Equities continued to slump in the Asia-Pacific region, with many large markets off more than 1%, led by Australia's more than 2% decline. However, European equities are moving higher, and the Dow Jones Stoxx 600 is up about 0.8% in late morning turnover that saw nearly all the main industry groups advance. Energy, consumer staples, and